Medesis Pharma SA Tangible Net Worth Ratio
Medesis Pharma SA tangible net worth ratio. Medesis Pharma SA (ALMDP) has a Tangible Net Worth Ratio of -99.3% as of June 2022. This metric is calculated by deducting intangible assets (€232.38K) from net assets (€116.62K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check ALMDP strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Medesis Pharma SA (2021–2021)
Tangible net worth ratio of Medesis Pharma SA from 2021 to 2021. This chart shows how Medesis Pharma SA's Tangible Net Worth Ratio has changed across 1 annual periods from 2021 to 2021. As of June 2022, the ratio stands at -99.3%, reflecting net assets of €116.62K with intangible assets of €232.38K EUR. See Medesis Pharma SA working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Medesis Pharma SA Tangible Net Worth Ratio by Year (2021–2021)
Medesis Pharma SA tangible net worth ratio by year from 2021 to 2021. The table below presents the year-by-year Tangible Net Worth Ratio for Medesis Pharma SA from 2021 to 2021, covering 1 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see ALMDP market cap.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2021 | 84.7% | €1.65 Million | €252.53K | €4.33 Million | — |